Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 22;33(4):e014524.
doi: 10.1590/S1984-29612024064. eCollection 2024.

Optimization and workflow of in vitro culture of adult Fasciola hepatica

Affiliations

Optimization and workflow of in vitro culture of adult Fasciola hepatica

Cesar Burga-Cisterna et al. Rev Bras Parasitol Vet. .

Abstract

The aim of this study was to evaluate different transportation and incubation conditions to test the viability of adult Fasciola hepatica in order to propose a new cultivation workflow. The adult stage of F. hepatica was obtained from naturally infected cattle at a local slaughterhouse in Lima, Peru. Different transport and incubation conditions of F. hepatica were tested, evaluating its viability through a motility scale. DMEM and RPMI 1640 media presented better transport conditions compared to Hedon-Fleig and PBS media (p < 0.001), maintaining the flukes at 37°C. Also, DMEM and RPMI-1640 media presented better incubation conditions compared to Hedon-fleig (p < 0.001). A minimum of 3 ml of medium per fluke was required to maintain best viability (p < 0.001) and no differences in viability were found between the different types of culture plates (p > 0.05). In addition, we found that incubation with DMSO (dimethyl sulfoxide) at concentrations greater than 0.5% v/v for 48 hours generates toxicity (p < 0.001). In conclusion, RPMI 1640 and DMEN media presented better transport and in vitro cultivation conditions for F. hepatica, using DMSO at concentrations lower than 0.5% v/v.

O objetivo deste estudo foi avaliar diferentes condições de transporte e incubação, para testar a viabilidade de Fasciola hepatica adulta, a fim de propor um novo fluxo de cultivo. O estágio adulto de F. hepatica foi obtido de bovinos, naturalmente infectados, em um matadouro local em Lima, Peru. Foram testadas várias condições de transporte e incubação de F. hepatica, avaliando sua viabilidade por meio de uma escala de motilidade. Os meios DMEM e RPMI 1640 apresentaram melhores condições de transporte em comparação com os meios Hedon-Fleig e PBS (p < 0,001), mantendo os vermes a 37°C. Além disso, os meios DMEM e RPMI-1640 apresentaram melhores condições de incubação em comparação ao Hedon-fleig (p < 0,001). Foi necessário um mínimo de 3 ml de meio por verme para manter a melhor viabilidade (p < 0,001) e não foram encontradas diferenças na viabilidade entre os diferentes tipos de placas de cultura (p > 0,05). Além disso, foi constatado que a incubação com DMSO (dimetilsulfóxido) em concentrações superiores a 0,5% v/v, por 48 horas, gera toxicidade (p < 0,001). Conclui-se que os meios RPMI 1640 e DMEN apresentaram melhores condições de transporte e cultivo in vitro para F. hepatica, utilizando DMSO em concentrações inferiores a 0,5% v/v.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1. In vitro culture workflow of adult stage of Fasciola hepatica.

References

    1. Aftab A, Raina OK, Maxton A, Masih SA. Advances in diagnostic approaches to Fasciola infection in animals and humans: an overviews. J Helminthol. 2024;98:e12. doi: 10.1017/S0022149X23000950. - DOI - PubMed
    1. Alsulami MN, Mohamed K, Wakid MH, Abdel-Gaber R, Timsah AG, Al-Megrin WAI, et al. Molecular characterization of Fasciola hepatica in sheep based on DNA Sequences of Ribosomal ITS-1. Infect Drug Resist. 2023;16:6661–6671. doi: 10.2147/IDR.S421206. - DOI - PMC - PubMed
    1. Cantor JR. The rise of physiologic media. Trends Cell Biol. 2019;29(11):854–861. doi: 10.1016/j.tcb.2019.08.009. - DOI - PMC - PubMed
    1. Caravedo MA, Cabada MM. Human fascioliasis: current epidemiological status and strategies for diagnosis, treatment, and control. Res Rep Trop Med. 2020;11:149–158. doi: 10.2147/RRTM.S237461. - DOI - PMC - PubMed
    1. Duthaler U, Smith TA, Keiser J. In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78. Antimicrob Agents Chemother. 2010;54(11):4596–4604. doi: 10.1128/AAC.00828-10. - DOI - PMC - PubMed

LinkOut - more resources